Back to top
more

DexCom (DXCM)

(Delayed Data from NSDQ)

$76.44 USD

76.44
7,419,542

-0.11 (-0.14%)

Updated Sep 17, 2025 04:00 PM ET

Pre-Market: $76.77 +0.33 (0.43%) 8:56 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (86 out of 245)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

John Blank headshot

No Gatherings of 50 People or More: Global Week Ahead

by John Blank

The struggle arrived from solving this riddle: It is the Travel & Leisure industry buckling completely that is more important than the Fed's surprise Sunday action.

Tirthankar Chakraborty headshot

New Strong Buy Stocks for March 16th

by Tirthankar Chakraborty

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:

Zacks Equity Research

DexCom (DXCM) Down 3.3% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

DexCom (DXCM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Is DexCom (DXCM) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (DXCM) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?

by Zacks Equity Research

Sector ETF report for XHE

Zacks Equity Research

DexCom (DXCM) Stock Moves -1.89%: What You Should Know

by Zacks Equity Research

In the latest trading session, DexCom (DXCM) closed at $247.64, marking a -1.89% move from the previous day.

Zacks Equity Research

Masimo Inks Deal With Imprivata, Improves Patient Monitoring

by Zacks Equity Research

Masimo's (MASI) partnership with Imprivata is likely to boost patient outcomes through the integration of Imprivata Medical Device Access into Masimo's Hospital Automation solutions.

Zacks Equity Research

Here's Why You Should Retain HMS Holdings (HMSY) Stock Now

by Zacks Equity Research

HMS Holdings (HMSY) is gaining traction from growing PI and TPM analytical services.

Zacks Equity Research

Here's Why You Should Invest in Intuitive Surgical Stock Now

by Zacks Equity Research

Intuitive Surgical (ISRG) continues to benefit from da Vinci surgical system, strong global foothold and solid recurring revenue base. However, stiff competition remains a woe.

Zacks Equity Research

Here's Why You Should Hold on to OPKO Health Stock for Now

by Zacks Equity Research

OPKO Health (OPK) continues to gain from RAYALDEE and BioReference platforms, and focus on R&D despite operating losses.

Zacks Equity Research

Here's Why You Should Invest in Integer Holdings Stock Now

by Zacks Equity Research

Integer Holdings (ITGR) continues to benefit from portfolio management, strong foothold in the broader MedTech space and rising Non-Medical sales.

Zacks Equity Research

Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (DXCM) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Is Dexcom (DXCM) a Great Growth Stock?

by Zacks Equity Research

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Dexcom (DXCM).

Zacks Equity Research

Insulet Partners With Dexcom for Automated Insulin Delivery

by Zacks Equity Research

This agreement is a major step forward in Insulet's (PODD) commitment toward bolstering its automated insulin delivery system and providing better clinical outcomes for diabetes patients.

Zacks Equity Research

Increased Earnings Estimates Seen for DexCom (DXCM): Can It Move Higher?

by Zacks Equity Research

DexCom (DXCM) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.

Zacks Equity Research

Why DexCom (DXCM) Stock Might be a Great Pick

by Zacks Equity Research

DexCom (DXCM) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Zacks Equity Research

Will DexCom Continue to Surge Higher?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in DexCom.

Zacks Equity Research

Can Dental Growth Drive Henry Schein's (HSIC) Q4 Earnings?

by Zacks Equity Research

Consistent contribution from Henry Schein One is likely to have benefited Henry Schein's (HSIC) Q4 performance.

Zacks Equity Research

DexCom (DXCM) Q4 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

DexCom's (DXCM) fourth-quarter earnings benefit from higher revenues and solid performing Sensor and Transmitter segments.

Zacks Equity Research

Baxter (BAX) and COSMED Receive FDA Clearance for Q-NRG+

by Zacks Equity Research

The latest FDA clearance is likely to boost Baxter's (BAX) Clinical Nutrition segment.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Waste Management, TC Energy, Duke Energy, DexCom and Republic Services

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Waste Management, TC Energy, Duke Energy, DexCom and Republic Services

Zacks Equity Research

HealthEquity (HQY) to Report Q4 Earnings: What's in Store?

by Zacks Equity Research

HealthEquity's (HQY) fourth-quarter fiscal 2020 earnings are likely to reflect top-line growth and higher HSA member growth.

Urmimala Biswas headshot

Medical Products Stock Q4 Earnings on Feb 13: DXCM, LH & More

by Urmimala Biswas

Strong foothold in the emerging markets so far widely contributes to some of the industry players' Q4 results.

Zacks Equity Research

Why Earnings Season Could Be Great for DexCom (DXCM)

by Zacks Equity Research

DexCom (DXCM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Equity Research

InMode (INMD) to Post Q4 Earnings: What's in the Cards?

by Zacks Equity Research

InMode's (INMD) Q4 performance is likely to have been driven by developments in business segments.